Immunohistochemical Expression of Endothelin-1 and Endothelin-A and Endothelin-B Receptors in High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer

European Urology

Volumn 52, Issue 6, 2007, Pages 1682-1690

  Montironi, Rodolfo ^a   Mazzucchelli, Roberta ^a   Barbisan, Francesca ^a   Stramazzotti, Daniela ^a   Santinelli, Alfredo ^a   Lòpez Beltran, Antonio ^b   Cheng, Liang ^c   Montorsi, Francesco ^d   Scarpelli, Marina ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Cystoprostatectomy; Endothelin 1; Endothelin A receptor; Endothelin B receptor; High grade prostatic intraepithelial neoplasia; Insignificant cancer; Prostate cancer; Significant cancer

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; KI 67 ANTIGEN;

ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIN-1; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B;

EID: 35348833842     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.02.024     Document Type: Article

References (23)

1. Nelson J., Bagnato A., Battistini B., et al. The endothelin axis: emerging role in cancer. Nat Rev Cancer 3 (2003) 110-116
2. Peduto Eberl L., Bovey R., and Juillerat-Jeanneret L. Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells. Br J Cancer 88 (2003) 788-795
3. Godara G., Cannon G.W., Cannon Jr. G.M., et al. Role of endothelin axis in progression to aggressive phenotype of prostate adenocarcinoma. Prostate 65 (2005) 27-34
4. Nelson J.B., Udan M.S., Guruli G., et al. Endothelin-1 inhibits apoptosis in prostate cancer. Neoplasia 7 (2005) 631-637
5. Grant E.S., Brown T., Roach A., et al. In vitro expression of endothelin-1 (ET-1) and the ETA and ETB ET receptors by the prostatic epithelium and stroma. J Clin Endocrinol Metab 82 (1997) 508-513
6. Kobayashi S., Tang R., Wang B., et al. Localization of endothelin receptors in the human prostate. J Urol 151 (1994) 763-766
7. Nelson J.B., Hedican S.P., George D.J., et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1 (1995) 944-949
8. Carducci M.A., Padley R.J., Breul J., et al. Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. J Clin Oncol 21 (2003) 679-689
9. Herrmann E., Bogemann M., Bierer S., et al. the endothelin axis in urologic tumor: mechanisms of tumor biology and therapeutic implications. Exp Rev Anticancer Ther 6 (2006) 73-81
10. Zonnenberg B.A., Groenewegen G., Janus T.J., et al. Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: an endothelin receptor antagonist for refractory prostate cancer. Clin Cancer Res 9 (2003) 2965-2972
11. de Matteis A., Guidi A., Di Paolo B., et al. Endothelin-1 in human prostatic carcinoma treated with androgen withdrawal: an immunohistochemical study. Cancer 91 (2001) 1933-1939
12. Granchi S., Brocchi S., Bonaccorsi L., et al. Endothelin-1 production by prostate cancer cell line is up-regulated by factors involved in cancer progression and down-regulated by androgens. Prostate 49 (2001) 267-277
13. Montironi R., Mazzucchelli R., Santinelli A., et al. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol 36 (2005) 646-654
14. Wulfing P., Diallo R., Kersting C., et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin Cancer Res 9 (2003) 4125-4131
15. Montironi R., Mazzucchelli R., Barbisan F., et al. HER-2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies. Comparison with clinically detected androgen-dependent and androgen-independent cancer. Hum Pathol 37 (2006) 1137-1144
16. Nelson J.B., Chan-Tack K., Hedican S.P., et al. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 56 (1996) 663-668
17. Gohji K., Kitazawa S., Tamada H., et al. Expression of endothelin receptor A associated with prostate cancer progression. J Urol 165 (2001) 1033-1036
18. Jeronimo C., Henrique R., Campos P.F., et al. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J Clin Pathol 56 (2003) 52-55
19. Hsu Y.H., and Huang S.C. Immunohistochemical localization of endothelin-converting enzyme-1 in neuroendocrine tumors and normal human tissue. Kaohsiung J Med Sci 19 (2003) 555-562
20. Padley R.J., Dixon D.B., and Wu-Wong J.R. Effect of castration on endothelin receptors. Clin Sci (Lond) 48 (2002) S442-S445
21. Takahashi W., Afiatpour P., Foster H.E., et al. The effect of castration on endothelins, their receptors and endothelin converting enzyme in rat prostate. Naunyn Schmiedebergs Arch Pharmacol 366 (2002) 166-176
22. Bostwick D.G., and Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol 17 (2004) 360-379
23. Kondo S., Morita T., and Tashima Y. Benign prostatic hypertrophy affects the endothelin receptor density in the human urinary bladder and prostate. Urol Int 54 (1995) 198-203